Menu
Search
|

Menu

Close
X

Simulations Plus Inc SLP.OQ (NASDAQ Stock Exchange Capital Market)

20.16 USD
-- (--)
As of Nov 14
chart
Previous Close 20.16
Open --
Volume --
3m Avg Volume 18,819
Today’s High --
Today’s Low --
52 Week High 23.95
52 Week Low 14.25
Shares Outstanding (mil) 17.37
Market Capitalization (mil) 351.47
Forward P/E 49.85
Dividend (Yield %) 0.06 ( 1.19 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
23
FY17
24
FY16
20
FY15
18
EPS (USD)
FY18
0.341
FY17
0.330
FY16
0.287
FY15
0.225
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
49.85
29.53
Price to Sales (TTM)
vs sector
12.02
22.95
Price to Book (MRQ)
vs sector
11.29
4.15
Price to Cash Flow (TTM)
vs sector
33.51
20.94
Total Debt to Equity (MRQ)
vs sector
0.00
15.47
LT Debt to Equity (MRQ)
vs sector
0.00
11.13
Return on Investment (TTM)
vs sector
21.98
13.00
Return on Equity (TTM)
vs sector
25.73
14.69

EXECUTIVE LEADERSHIP

Walter Woltosz
Chairman of the Board, Since 2018
Salary: $180,000.00
Bonus: $36,000.00
Thaddeus Grasela
President, Director, Since 2014
Salary: $250,000.00
Bonus: $25,000.00
Shawn O'Connor
Chief Executive Officer, Since 2018
Salary: --
Bonus: --
John Kneisel
Chief Financial Officer, Since 2013
Salary: $169,504.00
Bonus: $11,657.00
John DiBella
Vice President - Sales & Marketing, Since 2012
Salary: $190,478.00
Bonus: $20,270.00

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

42505 10th St W
LANCASTER   CA   93534-7059

Phone: +1661.7237723

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.

SPONSORED STORIES